Search results
Down 16.6% in 4 Weeks, Here's Why You Should You Buy the Dip in TCR2 Therapeutics Inc. (TCRR)
Zacks via Yahoo Finance· 1 year agoTCR2 Therapeutics Inc. (TCRR) is technically in oversold territory now, so the heavy selling...
What Kind Of Shareholders Hold The Majority In TCR2 Therapeutics Inc.'s (NASDAQ:TCRR) Shares?
Simply Wall St. via Yahoo Finance· 2 years agoThe big shareholder groups in TCR2 Therapeutics Inc. (NASDAQ:TCRR) have power over the company....
TCR2 Therapeutics Shares Jump After Additional Reponses in Ovarian Cancer, Mesothelioma
Benzinga via Yahoo Finance· 2 years agoTCR2 Therapeutics Inc (NASDAQ: TCRR) has announced topline results from the Phase 1 portion of the...
Is TCR2 Therapeutics (NASDAQ:TCRR) In A Good Position To Deliver On Growth Plans?
Simply Wall St. via Yahoo Finance· 1 year agoJust because a business does not make any money, does not mean that the stock will go down. For...
Will TCR2 Therapeutics (NASDAQ:TCRR) Spend Its Cash Wisely?
Simply Wall St. via Yahoo Finance· 2 years agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
Adaptimmune Agrees To Merge With Another Cell Therapy Focused Company
Benzinga via Yahoo Finance· 1 year agoAdaptimmune Therapeutics plc (NASDAQ: ADAP) is merging with TCR² Therapeutics Inc (NASDAQ: TCRR) in...